查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553661

質子束治療系統市場規模、佔有率、趨勢分析報告：按產品、類型、地區和細分市場預測，2024-2030

Proton Therapy Systems Market Size, Share & Trends Analysis Report By Product (Equipment, Services), By Type (Single-Room System, Multi-Room System), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

質子治療系統市場成長與趨勢

Grand View Research, Inc.的研究報告顯示，預計2024年至2030年全球質子治療系統市場規模將以7.3%的複合年成長率成長，2030年將達到12億美元。

這個市場主要由質子治療中心的增加、癌症病例的增加以及醫院設立中心的投資增加所推動。

醫院、製造商和私人投資者不斷增加的資金和投資也促進了該市場的成長。例如，2015年8月，Mevion Medical Systems（美國）獲得由厚朴投資（中國）和元明資本（中國）主導的2億美元股權融資。這些資金很可能用於開發技術先進且低成本的產品。此外，各地區政府都已列入建立此類中心的預算。例如，2015年7月，維多利亞州政府撥款約200萬澳元（153萬美元）在維多利亞綜合癌症中心（VCCC）建立國家質子治療中心。

此外，全球癌症患者數量的快速增加預計將推動預測期內的市場成長。據美國癌症協會稱，2017 年美國將診斷出 1,688,780 例新癌症病例，約 600,920 人將死於該疾病。此外，根據《刺胳針》報道，到 2030 年，被診斷出乳房腫瘤的女性人數預計將達到 320 萬人，幾乎是 2015 年 170 萬人的兩倍。

美國和歐洲國家有利的報銷政策以及新興國家癌症相關醫療費用的增加可能會推動全球質子治療系統市場的發展。此外，成本下降、認知提高和質子治療採用率的提高預計將在預測期內推動對這些系統的需求。然而，建立這些中心的高成本以及新興國家缺乏報銷可能會限制未來幾年的成長。

質子治療系統市場報告亮點

  • 由於建立質子治療中心的合約數量增加，設備部門佔據了2023年大部分收益佔有率。
  • 多房間系統在 2030 年佔據最大的市場收益佔有率，達到 67.4%。
  • 2023年北美質子治療系統市場佔42.7%的市場佔有率。
  • 預計亞太質子治療系統市場在預測期內複合年成長率最快。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章質子束治療系統市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 質子束治療系統市場分析工具
    • 波特的分析
    • PESTEL分析

第4章質子束治療系統市場：依產品估計和趨勢分析

  • 細分儀表板
  • 質子治療系統市場：2023 年和 2030 年產品變化分析
  • 裝置
  • 服務

第5章質子束治療系統市場：按類型估計和趨勢分析

  • 細分儀表板
  • 質子治療系統市場：類型變化分析，2023 年和 2030 年
  • 單間系統
  • 多房間系統

第6章質子束治療系統市場：區域、估計和趨勢分析

  • 2023 年及 2030 年質子治療系統市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Ion Beam Applications SA
    • Optivus Proton Therapy, Inc.
    • Mevion Medical Systems
    • Advanced Oncotherapy plc
    • Varian Medical Systems, Inc
    • ProTom International, Inc
    • Hitachi, Ltd.
    • Mitsubishi Corporation
    • ProNova Solutions, LLC
    • Sumitomo Heavy Industries, Ltd
簡介目錄
Product Code: GVR-1-68038-499-4

Proton Therapy Systems Market Growth & Trends:

The global proton therapy systems market size is expected to reach USD 1.2 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030, according to a report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global proton therapy systems market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

Proton Therapy Systems Market Report Highlights:

  • The equipment segment held majority of the revenue share in 2023 due to rise in the number of contracts for establishment of proton therapy centers
  • The multi-room systems accounted for the largest market revenue share of 67.4% in 2030
  • North America proton therapy systems market dominated in 2023 and accounted for the market share of 42.7%.
  • Asia Pacific proton therapy systems market is estimated to register the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Proton Therapy Systems Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Proton Therapy Systems Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Proton Therapy Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Proton Therapy Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Proton Therapy Systems Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Proton Therapy Systems Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Single-Room Systems
    • 5.3.1. Single-Room Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Multi-Room Systems
    • 5.4.1. Multi-Room Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Proton Therapy Systems Market: Regional Estimates & Trend Analysis

  • 6.1. Proton Therapy Systems Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Ion Beam Applications S.A.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Optivus Proton Therapy, Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Mevion Medical Systems
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Advanced Oncotherapy plc
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Varian Medical Systems, Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. ProTom International, Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Hitachi, Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Mitsubishi Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. ProNova Solutions, LLC
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Sumitomo Heavy Industries, Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives